FSD: Peptides and Personalized Medicine
Episode publishedPodcast: Lumida Wealth : Non-Consensus...Lumida Wealth : Non-Consensus Invest Beyond the Ordinary
Transcript preview
Preview only
Hey, guys. Hope everyone is doing well. It's our next FSD. We got a a dual session here. A dual session. My buddy, Matt, flew in today. Matt's gonna drop some wisdom around peptides. Matt is the guy that got me into peptides. K? So thank you, Matt. He's been educating me. He's got a lot of insight to share around this. What was the expression you just shared?
Oh, well, first of all, I am not a doctor, don't play one on TV. Not
a medical device.
So everything I've done is just from research and things I've done to myself, but I just wanna put that out there. But we were just talking about the GLPs. You have GLP one, GLP two, GLP three, GLP one single agnostic, and that's like Ozempic. GLP two is tirzepatide. GLP three is the red to dried. And, you know, I was just telling Ram, if you see anyone that's lost weight, I'll give you a ninety percent chance that that person has been on some type of GLP one.
Well, you had a you had a great quote a second ago, which was the healthy man is a
100%. Yeah. It's just like as far as investment opportunities, I think health is still underestimated because at the end of the day, that's the most important thing. And there's an old saying that a healthy man has a thousand problems and a sick man has one. So or if you talk to someone who's 90 years old, worth a billion dollars, and you said, how much would you pay to, you know, be 20 again, they would tell you a billion dollars.
Yeah. 100%. 100%.
At the end of the day and we were talking about escape longevity, which is this belief that, like, within five years, every year you live, you're gonna gain a year of longevity. And right now, people think it's about 30 or 40%. So as crazy as it sounds, I think you have to be open minded that if you have, you know, the financial ability to invest in your health, you could live to one twenty, one fifty.
Yeah. The the longevity is going up. You can debate whether we bend the curve down and essentially people die from accidents or, malevolent actions, I suppose, but natural death goes away. Like, question number one is what happens to equity risk premia? The demand for long duration security is gonna go up. Right? Two, what happens to insurance companies? Matt brought up this point too. Like, they the liabilities on insurance companies go down. Like, life insurance claims drop quite a bit.
Keep exploring with a free account.
A free account preserves the short preview. Upgrade to Pro for the full transcript and episode chat.